Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer.

Authors

Jianqing Lin, George Washington University
Jacob Elkon, George Washington University
Brittany Ricart, George Washington University
Erica Palmer, George Washington University
Christian Zevallos-Delgado, George Washington University
Satish Noonepalle, George Washington University
Brooke Burgess, George Washington University
Robert Siegel, George Washington University
Yan Ma, George Washington University
Alejandro Villagra, George Washington University

Document Type

Journal Article

Publication Date

12-1-2021

Journal

The Oncologist

Volume

26

Issue

12

Inclusive Pages

e2136-e2142

DOI

10.1002/onco.13957

Keywords

Benzamides; Humans; Leukocytes, Mononuclear; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Pyridines

Comments

Epub 2021 Sep 14

APA Citation

Lin, J., Elkon, J., Ricart, B., Palmer, E., Zevallos-Delgado, C., Noonepalle, S., Burgess, B., Siegel, R., Ma, Y., & Villagra, A. (2021). Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer.. The Oncologist, 26 (12). http://dx.doi.org/10.1002/onco.13957

Peer Reviewed

1